Kiromic Biopharma, Inc. Quarterly Interest Expense in USD from Q3 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Kiromic Biopharma, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2019 to Q4 2022.
  • Kiromic Biopharma, Inc. Interest Expense for the quarter ending December 31, 2022 was $160K, a 2605% increase year-over-year.
  • Kiromic Biopharma, Inc. Interest Expense for the twelve months ending December 31, 2022 was $167K, a 1265% increase year-over-year.
  • Kiromic Biopharma, Inc. annual Interest Expense for 2022 was $167K, a 1265% increase from 2021.
  • Kiromic Biopharma, Inc. annual Interest Expense for 2021 was $12.2K, a 270% increase from 2020.
  • Kiromic Biopharma, Inc. annual Interest Expense for 2020 was $3.3K, a 85.3% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $167K $160K +$154K +2605% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 $12.8K $1.4K +$900 +180% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $11.9K $2.7K +$600 +28.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $11.3K $2.8K -$900 -24.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $12.2K $5.9K Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $500 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.1K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $3.7K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2019 $7.4K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.